Latest Becker's muscular dystrophy Stories
Data Supports Benefit in Nonsense Mutation Duchenne Muscular Dystrophy Patients SOUTH PLAINFIELD, N.J., Oct. 27, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
CLEVELAND and COLUMBUS, Ohio, Oct.
WACO, Texas, Sept.
However, Less Than One-Third of Duchenne Patients Are in Subpopulations That Will Benefit From New Disease-Modifying Therapies, According to Findings from Decision Resources Group BURLINGTON,
-Top-line data expected H2 2015- SOUTH PLAINFIELD, N.J., Sept. 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
-French ATU Cohort and Other Named Patient Programs Authorized - SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
Parent Project Muscular Dystrophy-led guidance seeks to address unmet clinical needs of individuals with Duchenne muscular dystrophy and accelerate development of safe and effective therapies CHICAGO,
HACKENSACK, N.J., Feb.
Recent scientific development represents progress in FSHD research. Lexington, Mass.
- Large; stout; burly.